Literature DB >> 25948738

Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins.

Kirsten Holthusen1, Pooja Talaty1, David N Everly2.   

Abstract

UNLABELLED: Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) induces constitutive signaling in EBV-infected cells to ensure the survival of the latently infected cells. LMP1 is localized to lipid raft domains to induce signaling. In the present study, a genome-wide screen based on bimolecular fluorescence complementation (BiFC) was performed to identify LMP1-binding proteins. Several actin cytoskeleton-associated proteins were identified in the screen. Overexpression of these proteins affected LMP1-induced signaling. BiFC between the identified proteins and LMP1 was localized to lipid raft domains and was dependent on LMP1-induced signaling. Proximity biotinylation assays with LMP1 induced biotinylation of the actin-associated proteins, which were shifted in molecular mass. Together, the findings of this study suggest that the association of LMP1 with lipid rafts is mediated at least in part through interactions with the actin cytoskeleton. IMPORTANCE: LMP1 signaling requires oligomerization, lipid raft partitioning, and binding to cellular adaptors. The current study utilized a genome-wide screen to identify several actin-associated proteins as candidate LMP1-binding proteins. The interaction between LMP1 and these proteins was localized to lipid rafts and dependent on LMP1 signaling. This suggests that the association of LMP1 with lipid rafts is mediated through interactions with actin-associated proteins.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948738      PMCID: PMC4473556          DOI: 10.1128/JVI.00321-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Epstein-Barr virus-associated Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Judy T Tellam; Rajiv Khanna
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

2.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

Authors:  V R Baichwal; B Sugden
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

4.  An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes.

Authors:  D Liebowitz; R Kopan; E Fuchs; J Sample; E Kieff
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

Review 5.  Epstein-Barr virus in the pathogenesis of NPC.

Authors:  Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

6.  Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.

Authors:  Ping Xie; Gail A Bishop
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 7.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Authors:  K Hennessy; S Fennewald; M Hummel; T Cole; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

Review 9.  AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment.

Authors:  Antonino Carbone
Journal:  Hum Pathol       Date:  2002-04       Impact factor: 3.466

10.  Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Authors:  Ellen D Cahir-McFarland; Kara Carter; Andreas Rosenwald; Jena M Giltnane; Sarah E Henrickson; Louis M Staudt; Elliott Kieff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  7 in total

1.  The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Authors:  Mark A Rider; Mujeeb R Cheerathodi; Stephanie N Hurwitz; Dingani Nkosi; Lauren A Howell; Deanna C Tremblay; Xia Liu; Fanxiu Zhu; David G Meckes
Journal:  Virology       Date:  2018-01-09       Impact factor: 3.616

Review 2.  Filling the Void: Proximity-Based Labeling of Proteins in Living Cells.

Authors:  Dae In Kim; Kyle J Roux
Journal:  Trends Cell Biol       Date:  2016-09-22       Impact factor: 20.808

3.  The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.

Authors:  Mujeeb R Cheerathodi; David G Meckes
Journal:  Future Virol       Date:  2018-12-03       Impact factor: 1.831

4.  Proximity labeling in mammalian cells with TurboID and split-TurboID.

Authors:  Kelvin F Cho; Tess C Branon; Namrata D Udeshi; Samuel A Myers; Steven A Carr; Alice Y Ting
Journal:  Nat Protoc       Date:  2020-11-02       Impact factor: 13.491

Review 5.  Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioID.

Authors:  Renata Varnaitė; Stuart A MacNeill
Journal:  Proteomics       Date:  2016-07-27       Impact factor: 3.984

6.  Parvovirus nonstructural protein 2 interacts with chromatin-regulating cellular proteins.

Authors:  Salla Mattola; Kari Salokas; Vesa Aho; Elina Mäntylä; Sami Salminen; Satu Hakanen; Einari A Niskanen; Julija Svirskaite; Teemu O Ihalainen; Kari J Airenne; Minna Kaikkonen-Määttä; Colin R Parrish; Markku Varjosalo; Maija Vihinen-Ranta
Journal:  PLoS Pathog       Date:  2022-04-08       Impact factor: 7.464

7.  Molecular characterization of Epstein-Barr virus variants detected in the oral cavity of adolescents in Cali, Colombia

Authors:  Daniela Arturo-Terranova; Sebastián Giraldo-Ocampo; Andrés Castillo
Journal:  Biomedica       Date:  2020-05-01       Impact factor: 0.935

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.